Long Term Results of Interferon Treatment in Hairy Cell Leukemia Italian Cooperative Group of Hairy Cell Leukemia (ICGHCL)

References

• Quesada J. R., Reuben J. R., Manning J. T., Hersh E. M., Gutterman J. U. Alpha interferon for induction of remission in hairy cell leukemia. N. Engl. J. Med. 1984; 310: 15–18
   PubMed Web of Science ®Google Scholar
• Worman C. P., Catovsky D., Bevan P. C., Camba L., Joyner M., Green P. J., William H. J. H., Bottomley J. M., Gordon-Smith E. C., Cawley J. C. Interferon is effective in hairy cell leukemia. Br. J. Haematol. 1985; 60: 759–763
   PubMed Web of Science ®Google Scholar
• Ratain M. J., Golomb H. M., Vardiman J. W., Vokes E. E., Jacobs R. H., Daly K. Treatment of hairy cell leukemia with recombinant alpha interferon. Blood 1985; 65: 644–648
   PubMed Web of Science ®Google Scholar
• Huber C., Flener R., Gastl G. Interferon-alpha-2c in the treatment of advanced hairy cell leukemia. Oncology 1985; 42: 7–9
   PubMed Web of Science ®Google Scholar
• Jacobs A. D., Naiem F., Champlin R. E., Golde D. W. Toxicity and bone marrow response of patients with hairy cell leukemia treated with biosyntetic (recombinant) alfa2-interferon. Blul 1985; 50: 33–34
   PubMedGoogle Scholar
• Thompson J. A., Brady J., Kidd P., Fefer A. Recombinant alpha-2 interferon in the treatment of hairy cell leukemia. Cancer Treat. Rep. 1985; 69: 791–793
   PubMedGoogle Scholar
• Foon K., Maluish A., Abrams P., Wrightington S., Stevenson H., Alarif A., Fer M., Overton W., Poole M., Schnipper E., Jaffe E., Herberman R. Recombinant leukocyte A interferon therapy for advanced hairy cell leukemia. Am. J. Med. 1986; 80: 351–356
   PubMed Web of Science ®Google Scholar
• Quesada J. R., Hersh E. M., Manning J., Reuben J., Keating M., Schnipper E., Itri L., Gutterman J. U. Treatment of hairy cell leukemia with recombinant alpha-interferon. Blood 1986; 68: 493–497
   PubMed Web of Science ®Google Scholar
• Golomb H. M., Jacobs A., Fefer A., Ozer H., Thompson J., Portlock C., Ratain M., Golde D., Vardiman J., Burke J., Brady J., Bonnem E., Spiegel R. Alpha-2-interferon therapy of hairy cell leukemia: A multicenter study of 64 patients. J. Clin. Oncol. 1986; 4: 900–905
   PubMed Web of Science ®Google Scholar
• Ehmann W. C., Silbert R. Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy. Am. J. Med. 1986; 80: 1111–1114
   PubMed Web of Science ®Google Scholar
• Bememan Z. N., Gastl G., Gangji D., Van Camp B., Jochmans K., Aulitzky W., Flamest J., Peetermans M. E., Huber C. Treatment of hairy cell leukemia with recombinant alpha-interferon. Eur. J. Cancer Clin. Oncol. 1986; 22: 987–990
   PubMedGoogle Scholar
• Golomb H. M., Fefer A., Golde D. W., Oxer H., Port-Lock R., Silber R., Rappeport J., Ratain M. J., Thompson J., Bonnem E. M., Spiegel R. J., Tensen L., Burke J. S., Vardiman J. W. Sequential evaluation of alpha 2b interferon treatment in 128 patients with hairy cell leukemia. Semin. Oncol. 1987; 14: 13–17
   PubMed Web of Science ®Google Scholar
• Glaspy J. A., Jacobs A. D., Golde D. W. The UCLA experience with type I interferons in hairy cell leukemia. Leukemia 1987; 1: 323–326
   PubMed Web of Science ®Google Scholar
• Braide I., Hippe E. Hairy cell leukemia treated with interferon alpha 2b. J. Interferon Res. 1987; 7: 679–683
   Google Scholar
• Worman C. P., Catovsky D., Cawley J. C., et al. The U.K. experience with human lymphoblastoid interferon in hairy cell leukemia. A report of the First 50 cases. Leukemia 1987; 1: 320–322
   PubMed Web of Science ®Google Scholar
• Golomb H. M., Ratain M. J., Fefer A., et al. Randomized study of the duration of treatment with interferon alfa 2b in patients with hairy cell leukemia. J. Natl. Cancer Inst. 1988; 80: 369–373
   PubMed Web of Science ®Google Scholar
• Worman C. P., Nethersell A. B., Bottomley J. M., et al. Natural IFN-alpha therapy in hairy cell leukemia (Namalva-type IFN-Wellferon). Klin. Wochenschrift 1987; 65: 685–687
   PubMedGoogle Scholar
• Federico M., Chisesi T., Lauria F., Bernasconi C., Cap-Nist G., Castoldi G., Damasio E., Pagnucco G., Frassol-Dati A., Resegotti L., Silingardi V., Italian Cooperative Study Group for Hairy Cell Leukemia. Human lymphoblastoid interferon as initial therapy in hairy cell leukemia: A multicentre study in non-splenectomized patients. Br. J. Haematol. 1989; 72: 54–56
   PubMed Web of Science ®Google Scholar
• Glaspy J. A., Marcus S. G., Ambersley J., Golde D. W. Recombinant beta-serine-interferon in hairy cell leukemia compared prospectively with results with recombinant alpha-interferon. Cancer 1989; 64: 409–413
   PubMed Web of Science ®Google Scholar
• Liberati A. M., Fizzotti M., Di Clemente F., et al. Response to intermediate and standard doses of interferon- beta in hairy cell leukemia. Leuk. Res. 1990; 14: 779–784
   PubMed Web of Science ®Google Scholar
• Berman E., Heller G., Kempin S., Gee T., Tran L., Clarkson B. Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alfa-2a. Blood 1990; 75: 839–845
   PubMed Web of Science ®Google Scholar
• Damasio E. E., Federico M., Frassoldati A., Lamparelli T., Annino L., Bernasconi C., Chisesi T., Fo R., Lauria F., Pagnucco G., Resegotti L., For the ICGHCL. Splenectomy after initial therapy with alfa- interferon in patients with hairy cell leukemia (HCL): a multicenter study by the Italian Cooperative Group for Hairy Cell Leukemia. Preliminary results. Eur. J. Haematol. 1990, Suppl. 52: 29–31
   Google Scholar
• Smith I IJ. W., Longo D. L., Urba W. J., Clark J. W., Watson T., Beveridge J., Conlon K. C., Sznol M., Creek-More P., Alvord W. G., Lawrence J. B., Steis R. G. Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon alpha 2a. Blood 1991; 78: 1664–1667
   PubMed Web of Science ®Google Scholar
• Capnist G., Federico M., Chisesi T., Resegotti L., Pag-Nucco G., Castoldi G. L., Lamparelli T., Frassoldati A., Guamaccia C., Leoni P., Fabris P., Rossi G., Invernizzi R., Ambrosetti A., Bernasconi C., Damaslo E. Should alfa interferon be used as primary treatment for hairy cell leukemia?. Leuk. Res. 1991; 15: 419–426
   PubMed Web of Science ®Google Scholar
• Nielsen B., Braide I. Three years' continuous low-dose interferon-alpha treatment of hairy-cell leukaemia: Evaluation of response and maintenance dose. Eur. J. Haematol. 1992; 49: 174–179
   PubMed Web of Science ®Google Scholar
• Chang K. L., Stroup R., Weiss L. M. Hairy cell leukemia. Current status. Am. J. Clin. Pathol. 1992; 97: 719–738
   PubMed Web of Science ®Google Scholar
• Consensuse solution R. Proposed criteria for evaluation of response to treatment in hairy cell leukemia. Leukemia 1987; 1: 405
   Web of Science ®Google Scholar
• Jansen J., Hermans J. Splenectomy in hairy cell leukemia: A retrospective multicenter analysis. Cancer 1981; 47: 2066–2076
   PubMed Web of Science ®Google Scholar
• Ratain M. J., Golomb H. M., Vardiman J. W., Westbrook C. A., Barker C., Hooberman A., Bitter M. A., Daly K. Relapse after interferon alfa-2b therapy for hairy cell leukemia: analysis of prognostic variables. J. Clin. Oncol. 1988; 6: 1714–1721
   PubMed Web of Science ®Google Scholar
• Pangalis G. A., Boussiotis V. A., Kittas C., Panayiotidis P. G., Loukopoulos D., Fessas P. Hairy cell leukemia: Splenectomy after alpha 2b interferon therapy. Blood 1991; 78: 1385
   PubMed Web of Science ®Google Scholar
• Damasio E. E., Resegotti L., Capnist G., Federico M., Foa R., Francia P., Lamparelli T., ICGHCL. Hairy cell leukemia: splenectomy after alfa2b-interferon therapy. Blood 1991; 79: 1381
   Web of Science ®Google Scholar
• Golomb H. M., Fefer A., Golde D. W., et al. Report of a multi-institutional study of 193 patients with hairy cell leukemia treated with interferon alfa 2b. Semin. Oncol. 1988; 15: 7–9
   PubMed Web of Science ®Google Scholar
• Dearden C., Catovsky D. Treatment of hairy cell leukemia with 2′-deoxyxoformycin. Leukemia and Lymphoma 1990; 1: 179–185
   PubMedGoogle Scholar
• Habermann T. H., Andersen J. W., Cassileth P. A., Bennett M., Oken M. M. Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukemia. Br. J. Haematol. 1992; 80: 466–471
   PubMed Web of Science ®Google Scholar
• Piro L. D., Carrera C. J., Carson D. A., Beutler J. E. Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N. Engl. J. Med. 1990; 322: 1117–1120
   PubMed Web of Science ®Google Scholar
• Smalley R. V., Connors J., Tuttle R. L., Anderson S., Robinson W., Whisnant J. K. Splenectomy vs alpha-interferon. A randomized study in patients with previously untreated hairy cell leukemia. Am. J. HematoL 1992; 41: 13–18
   PubMed Web of Science ®Google Scholar
• Thaler J., Grunewald K., Gattringer C., Ho A. D., Weyrer K., Dietze O., Stauder R., Flukinger T., Lang A., Huber H. Long-term follow-up of patients with hairy cell leukemia treated with pentostatin-lymphocyte subpopulations and residual bone marrow infiltration. Br. J. Haematol. 1993; 84: 75–82
   PubMed Web of Science ®Google Scholar